Yishan Bio

Yishan Bio is a high-tech enterprise specializing in R&D, production, and promotion of tumor individualized medical testing products. It is a key high-tech enterprise under the National Torch Plan, a national intellectual property advantage enterprise, a pioneer and leader in China's individualized medical industry, and the first public company in China's individualized medical industry (stock code: 430620).
Yishan Bio has an international talent team, leading technology platforms, and modern R&D and production facilities, and independently develops leading individualized medical testing product series. Yishan holds Class III medical device production and operation qualifications in China, as well as ISO13485 and ISO15189 quality management system certifications. Its products have obtained NMPA (formerly CFDA) registration certificates and EU CE certification. The company has established independent medical testing institutions in multiple regions across the country, providing high-quality individualized medical testing products and services to tumor patients. Yishan Bio undertakes the construction of the 'Individualized Medical Public Technology Service Platform' and the 'Guangdong Provincial Individualized Medicine Engineering Technology Research Center', jointly funded by the central government and Guangdong Province. The Yishan headquarters building, integrating R&D, production, operations, and medical testing, is located on the scenic Guangzhou International Bio Island.